Your session is about to expire
← Back to Search
Photovoice for Spinal Cord Injury
N/A
Waitlist Available
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Experienced >1 fall since sustaining a SCI
Free of other conditions besides SCI that affect balance (e.g., vestibular disorder)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 7.5 months; change from start of baseline (phase i) to pre-intervention (phase ii) to post-intervention (phase iii) to end of 12-week follow-up
Awards & highlights
Study Summary
This trial will test the effects of a new treatment called Photovoice on confidence, falls, daily activities and quality of life for people with spinal cord injury.
Who is the study for?
This trial is for adults over 18 with spinal cord injury (SCI) who have fallen at least once since their injury. They must be living in the community, able to understand English, and use the internet. People with other conditions affecting balance or a progressive form of SCI are not eligible.Check my eligibility
What is being tested?
The study tests 'Photovoice,' a program combining photography and discussion to improve confidence in balance, reduce falls, enhance daily activity participation, and life quality for those with SCI. It includes photo tasks, interviews, group meetings over six weeks led by an SCI individual and a therapy or kinesiology expert.See study design
What are the potential side effects?
Since Photovoice involves non-medical interventions like photography and dialogue rather than drugs or surgery, it's not expected to have physical side effects. However, discussing experiences might bring up emotional responses.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have fallen more than once since my spinal cord injury.
Select...
I do not have any conditions affecting my balance other than SCI.
Select...
I am 18 years old or older.
Select...
I had a spinal cord injury more than a year ago.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 7.5 months; change from start of baseline (phase i) to pre-intervention (phase ii) to post-intervention (phase iii) to end of 12-week follow-up
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 7.5 months; change from start of baseline (phase i) to pre-intervention (phase ii) to post-intervention (phase iii) to end of 12-week follow-up
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Activities-specific Balance Confidence Scale
Falls Efficacy Scale - International
Spinal Cord Injury Falls Concern Scale
+1 moreSecondary outcome measures
Impact on Participation and Autonomy Questionnaire
Life Satisfaction Questionnaire 9
Survey of Activities and Fear of Falling in the Elderly
+1 moreOther outcome measures
Final Interview
Trial Design
1Treatment groups
Experimental Treatment
Group I: PhotovoiceExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
University Health Network, TorontoLead Sponsor
1,483 Previous Clinical Trials
486,488 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have fallen more than once since my spinal cord injury.I do not have any conditions affecting my balance other than SCI.I am 18 years old or older.You live in a community, not in an institution.You have a spinal cord injury with a rating from A to D on the American Spinal Injury Association Impairment Scale.I had a spinal cord injury more than a year ago.
Research Study Groups:
This trial has the following groups:- Group 1: Photovoice
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger